
Carbon, Journal Year: 2024, Volume and Issue: unknown, P. 119967 - 119967
Published: Dec. 1, 2024
Language: Английский
Carbon, Journal Year: 2024, Volume and Issue: unknown, P. 119967 - 119967
Published: Dec. 1, 2024
Language: Английский
Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 160311 - 160311
Published: Feb. 1, 2025
Language: Английский
Citations
1Carbon, Journal Year: 2025, Volume and Issue: unknown, P. 120122 - 120122
Published: Feb. 1, 2025
Language: Английский
Citations
1Carbon, Journal Year: 2025, Volume and Issue: 234, P. 119980 - 119980
Published: Jan. 4, 2025
Language: Английский
Citations
0Published: Jan. 1, 2025
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Language: Английский
Citations
0Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 533, P. 216510 - 216510
Published: Feb. 21, 2025
Language: Английский
Citations
0Diamond and Related Materials, Journal Year: 2025, Volume and Issue: 154, P. 112168 - 112168
Published: March 3, 2025
Language: Английский
Citations
0Small Structures, Journal Year: 2025, Volume and Issue: 6(3)
Published: March 1, 2025
The mechanism of the molecular photoluminescence carbon dots (CDs) has gained much attention recently, due to several reports formation small fluorophore species at reaction conditions applied in CD synthesis. In this work, two novel green‐emitting are discovered postsynthetic mixtures citric acid (CA)–urea CDs and identified as 3‐(4‐hydroxy‐1,3,6‐trioxo‐5 H ‐pyrrolo[3,4‐ c ]pyridine‐7‐yl)‐2,6‐dioxo‐piperidine‐4‐carboxyamide (HTPPC) 7‐[(2,5‐dioxopyrrolidin‐3‐yl)methyl]‐4‐hydroxy‐5 ]pyridine‐1,3,6‐trione (DMHPPT). less‐considered covalent character interactions between fluorophores structure is revealed during first steps frequently studied CA–urea CDs. Thus, specific sites HPPT (4‐hydroxy‐1 ]pyridine‐1,3,6(2 ,5 )‐trione), involved bonds with CDs, identified; origin reactive synthesis mixture revealed; spectroscopic consequences binding demonstrated using steady‐state time‐resolved spectroscopy methods accompanied by quantum chemical modeling. hypothesis suggesting expense validated experimentally. nature bonding involving a double bond functionalities successfully expanded citrazinic fluorophores, that similar can be present other dot systems.
Language: Английский
Citations
0ACS Applied Nano Materials, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Citations
0Nano Energy, Journal Year: 2025, Volume and Issue: unknown, P. 111053 - 111053
Published: April 1, 2025
Language: Английский
Citations
0Aggregate, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 28, 2024
ABSTRACT Carbon quantum dots (CQDs) represent a rapidly emerging class of nanomaterials with significant potential in biomedical applications due to their tunable fluorescence, high biocompatibility, and versatile functionalization. This review focuses on the recent progress utilizing CQDs for drug delivery, bioimaging, biosensing, cancer therapy. With unique optical properties, such as yield, photostability, enable precise bioimaging sensitive biosensing. Their small size, ease surface functionalization allow development targeted delivery systems, enhancing therapeutic precision minimizing side effects. In therapy, have shown photodynamic photothermal treatments by generating reactive oxygen species under light exposure, selectively targeting cells while sparing healthy tissues. Furthermore, CQDs’ ability penetrate biological barriers including blood–brain barrier opens new possibilities delivering agents hard‐to‐reach areas, tumors or diseased However, challenges optimizing synthesis, ensuring long‐term stability, addressing safety concerns environments remain critical hurdles. discusses current efforts overcome these improve CQD performance clinical settings, scalable production methods enhanced biocompatibility. As research progresses, are expected play an important role improving healthcare offering more treatment options contributing advancements personalized medicine.
Language: Английский
Citations
1